Managing Advanced EGFR-Mutant NSCLC: Expert and Patient Perspectives : Episode 8

Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC

February 4, 2025

Opinion

Video

Panelists discuss how Julia prepares patients for treatment with amivantamab, including educating them on potential side effects and incorporating proactive strategies into treatment management to optimize patient care and minimize adverse effects.

EP: 1.Overview of EGFR-Mutant Advanced NSCLC

EP: 2.EGFR-Mutant NSCLC Diagnosis: Insights from Patients and Clinicians

EP: 3.Coordinating Care for Patients with Advanced EGFR-Mutant NSCLC: A Multidisciplinary Approach

EP: 4.Multidisciplinary Care of EGFR-Mutant Advanced NSCLC: A Patient Perspective

EP: 5.Tailoring Patient Education and Resources in EGFR-Mutant Advanced NSCLC

EP: 6.Navigating EGFR-Mutant Advanced NSCLC Cancer Treatment: A Patient's Journey

EP: 7.Shared Decision Making in EGFR-Mutant Advanced NSCLC

Now Viewing

EP: 8.Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC

EP: 9.Intricacies of EGFR-Mutated NSCLC Care From the Patient Perspective

EP: 10.Patient Perspectives on Managing Side Effects from Amivantamab

EP: 11.Comprehensive Supportive Care for EGFR-Mutant Advanced NSCLC

EP: 12.Patient Perspective: Key Aspects of Supportive Care in the EGFR-Mutant Advanced NSCLC Journey

EP: 13.Future Perspectives in EGFR-Mutant Advanced NSCLC

Video content above is prompted by the following:

How do you prepare patients for treatment with amivantamab?
What side effects do you educate your patients on?
What proactive strategies do you incorporate into treatment management?

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!